Search Results - "HUANG, AHONG"

Refine Results
  1. 1

    Taxane chemotherapy vs antiandrogen agents as first‐line therapy for metastatic castration‐resistant prostate cancer by Sonpavde, Guru, Huang, Ahong, Wang, Li, Baser, Onur, Miao, Raymond

    Published in BJU international (01-06-2018)
    “…Objectives To assess treatment patterns and outcomes of patients with metastatic castration‐resistant prostate cancer (mCRPC) receiving first‐line chemotherapy…”
    Get full text
    Journal Article
  2. 2

    Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries by Cohen, Joshua, Beaubrun, Anne, Bashyal, Richa, Huang, Ahong, Li, Jieni, Baser, Onur

    Published in AIDS research and therapy (01-04-2020)
    “…Once-daily, single-tablet regimens (STRs) have been associated with improved patient outcomes compared to multi-tablet regimens (MTRs). This study evaluated…”
    Get full text
    Journal Article
  3. 3

    Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis by Armstrong, April W, Huang, Ahong, Wang, Li, Miao, Raymond, Patel, Miraj Y, Gadkari, Abhijit, Mallya, Usha G, Chao, Jingdong

    Published in PloS one (25-01-2019)
    “…At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis…”
    Get full text
    Journal Article
  4. 4

    Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States by Wu, Jashin J., Patel, Manish, Zeng, Feng, Huang, Ahong, Pan, Xing, Cao, Yiwen, Chen, Naijun, Photowala, Huzefa, Garg, Vishvas, Crowley, Jeff

    Published in The Journal of dermatological treatment (31-12-2023)
    “…To compare real-world dose escalation of risankizumab with other US Food and Drug Administration (FDA)-approved biologic treatments for management of…”
    Get full text
    Journal Article
  5. 5

    Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis by Patel, Charmi, Khoury, Antoine El, Huang, Ahong, Wang, Li, Bashyal, Richa

    Published in Current therapeutic research (01-01-2020)
    “…Schizophrenia is associated with high health care resource utilization and treatment costs. This study compared treatment patterns, health care resource…”
    Get full text
    Journal Article
  6. 6

    107-LB: Progression of Position of Basal Insulin in the Treatment of Type 2 Diabetes—A Real-World Analysis by SCHAPIRO, DAVID, MEEKS, ALEXANDRA, LIU, DONGJU, GELSEY, FELICIA, JUNEJA, RATTAN, PEREZ-NIEVES, MAGALY, HUANG, AHONG

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Background: In the past 5 years, type 2 diabetes practice guidelines have shifted to prioritize agents with cardiovascular (CV) and renal benefit. This study…”
    Get full text
    Journal Article
  7. 7

    92-LB: Higher Adherence and Persistence for Dulaglutide Compared with Oral Semaglutide at Six-Months Follow-Up with U.S. Real-World Data by PACZKOWSKI, ROSIRENE, HOOG, MEREDITH, PELESHOK, JENNIFER, YU, MARIA, HUANG, AHONG, LIMONE, BRENDAN, MANJELIEVSKAIA, JANNA

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…A retrospective, observational analysis of administrative claims data from the IBM MarketScan Databases assessed adherence and persistence among GLP-1 RA naive…”
    Get full text
    Journal Article
  8. 8

    Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs by Patel, Charmi, Huang, Ahong, Wang, Li, Paliwal, Yoshita, Joshi, Kruti

    Published in Advances in therapy (01-03-2022)
    “…Introduction Little is known about the burden of schizophrenia among United States veterans early after diagnosis. This retrospective study describes treatment…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate by Tagawa, Scott T., Ramaswamy, Krishnan, Huang, Ahong, Mardekian, Jack, Schultz, Neil M., Wang, Li, Sandin, Rickard, Lechpammer, Stanislav, George, Daniel J.

    Published in Prostate cancer and prostatic diseases (01-12-2021)
    “…Objective Evaluation of the comparative effectiveness of enzalutamide and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC)…”
    Get full text
    Journal Article
  11. 11

    Economic burden of treatment-resistant depression among veterans in the United States by Szukis, Holly, Joshi, Kruti, Huang, Ahong, Amos, Tony B., Wang, Li, Benson, Carmela J.

    Published in Current medical research and opinion (03-08-2021)
    “…Evidence is limited on the economic burden associated with treatment-resistant depression (TRD) among US veterans. We evaluated the economic burden among…”
    Get full text
    Journal Article
  12. 12

    Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer by George, Daniel J., Ramaswamy, Krishnan, Huang, Ahong, Russell, David, Mardekian, Jack, Schultz, Neil M., Janjan, Nora, Freedland, Stephen J.

    Published in Prostate cancer and prostatic diseases (01-09-2022)
    “…Background Black men are more likely to be diagnosed with aggressive prostate cancer (PC) and die from PC than white men. However, black men with metastatic…”
    Get full text
    Journal Article
  13. 13

    Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus by Chen, Jieling, Borra, Sujana, Fan, Ludi, Huang, Ahong, Patel, Dhiren, Juneja, Rattan

    Published in Journal of diabetes and its complications (01-10-2021)
    “…A dedicated Humulin R U-500 (U-500R) prefilled disposable insulin pen (KwikPen) became available in 2016, yet limited evidence exists on treatment patterns and…”
    Get full text
    Journal Article
  14. 14

    First-line chemotherapy (CT) versus anti-androgen therapy (AT) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Individual patient analysis of the Veterans Health Administration (VHA) dataset by Sonpavde, Guru, Huang, Ahong, Wang, Li, Baser, Onur, Miao, Raymond

    Published in Journal of clinical oncology (20-02-2017)
    “…Abstract only 156 Background: The outcomes of pts receiving first-line CT vs AT for mCRPC are unclear. Using the VHA dataset, we compared outcomes with…”
    Get full text
    Journal Article
  15. 15

    134-LB: Treatment Patterns and Outcomes Before and After Human Regular U-500 Insulin Initiation via Kwikpen in U.S. Veterans with Type 2 Diabetes by CHEN, JIELING, FAN, LUDI, JUNEJA, RATTAN, BORRA, SUJANA, HUANG, AHONG, WANG, LI

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Introduction: Human regular U-500 insulin (U-500R) improves glycemic control in people with type 2 diabetes (PwT2D) inadequately controlled with high doses of…”
    Get full text
    Journal Article
  16. 16

    1039-P: Treatment Patterns and Outcomes before and after Human Regular U-500 Insulin Initiation in Patients with Type 2 Diabetes Previously on <200 Units/Day of Insulin by HOOD, ROBERT C., FAN, LUDI, POLLOM, ROY D., BORRA, SUJANA, HUANG, AHONG, CHEN, JIELING

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Introduction: U-500 regular insulin (U-500R) was developed to help severely insulin-resistant patients meet high insulin requirements (>200 units/day). Here,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics by Ng-Mak, Daisy, Messali, Andrew, Huang, Ahong, Wang, Li, Loebel, Antony

    Published in The American journal of managed care (01-07-2019)
    “…This study compared the risk of hospitalization among adults with schizophrenia being treated with equivalent dose ranges of lurasidone versus aripiprazole,…”
    Get full text
    Journal Article
  19. 19

    Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer by Freedland, Stephen J., Ramaswamy, Krishnan, Huang, Ahong, Sandin, Rickard, Mardekian, Jack, Schultz, Neil M., Janjan, Nora, George, Daniel J.

    Published in Clinical genitourinary cancer (01-08-2023)
    “…•Most patients with nmCRPC have PSADT >12 months and a long natural history.•However, for those with shorter PSADT, the risk of metastasis and death, as well…”
    Get full text
    Journal Article
  20. 20